Jie Sun1, Xue-Qiao Zhao2, Niranjan Balu1, Moni B Neradilek3, Daniel A Isquith2, Kiyofumi Yamada1, Gádor Cantón4, John R Crouse5, Todd J Anderson6, John Huston7, Kevin O'Brien2, Daniel S Hippe1, Nayak L Polissar3, Chun Yuan1, Thomas S Hatsukami8. 1. Department of Radiology, University of Washington, Seattle, Washington. 2. Department of Medicine, University of Washington, Seattle, Washington. 3. The Mountain-Whisper-Light Statistics, Seattle, Washington. 4. Department of Mechanical Engineering, University of Washington, Seattle, Washington. 5. Department of Medicine, Wake Forest University, Winston-Salem, North Carolina. 6. Libin Cardiovascular Institute of Alberta and Cumming School of Medicine, Calgary, Alberta, Canada. 7. Department of Radiology, Mayo Clinic, Rochester, Minnesota. 8. Department of Surgery, University of Washington, Seattle, Washington. Electronic address: tomhat@u.washington.edu.
Abstract
OBJECTIVES: The aim of this study was to investigate whether and what carotid plaque characteristics predict systemic cardiovascular outcomes in patients with clinically established atherosclerotic disease. BACKGROUND: Advancements in atherosclerosis imaging have allowed assessment of various plaque characteristics, some of which are more directly linked to the pathogenesis of acute cardiovascular events compared to plaque burden. METHODS: As part of the event-driven clinical trial AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides: Impact on Global Health Outcomes), subjects with clinically established atherosclerotic disease underwentmulticontrast carotid magnetic resonance imaging (MRI) to detect plaque tissue composition and high-risk features. Prospective associations between MRI measurements and the AIM-HIGH primary endpoint (fatal and nonfatal myocardial infarction, ischemic stroke, hospitalization for acute coronary syndrome, and symptom-driven revascularization) were analyzed using Cox proportional hazards survival models. RESULTS: Of the 232 subjects recruited, 214 (92.2%) with diagnostic image quality constituted the study population (82% male, mean age 61 ± 9 years, 94% statin use). During median follow-up of 35.1 months, 18 subjects (8.4%) reached the AIM-HIGH endpoint. High lipid content (hazard ratio [HR] per 1 SD increase in percent lipid core volume: 1.57; p = 0.002) and thin/ruptured fibrous cap (HR: 4.31; p = 0.003) in carotid plaques were strongly associated with the AIM-HIGH endpoint. Intraplaque hemorrhage had a low prevalence (8%) and was marginally associated with the AIM-HIGH endpoint (HR: 3.00; p = 0.053). High calcification content (HR per 1 SD increase in percent calcification volume: 0.66; p = 0.20), plaque burden metrics, and clinical risk factors were not significantly associated with the AIM-HIGH endpoint. The associations between carotid plaque characteristics and the AIM-HIGH endpoint changed little after adjusting for clinical risk factors, plaque burden, or AIM-HIGH randomized treatment assignment. CONCLUSIONS: Among patients with clinically established atherosclerotic disease, carotid plaque lipid content and fibrous cap status were strongly associated with systemic cardiovascular outcomes. Markers of carotid plaque vulnerability may serve as novel surrogate markers for systemic atherothrombotic risk.
RCT Entities:
OBJECTIVES: The aim of this study was to investigate whether and what carotid plaque characteristics predict systemic cardiovascular outcomes in patients with clinically established atherosclerotic disease. BACKGROUND: Advancements in atherosclerosis imaging have allowed assessment of various plaque characteristics, some of which are more directly linked to the pathogenesis of acute cardiovascular events compared to plaque burden. METHODS: As part of the event-driven clinical trial AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides: Impact on Global Health Outcomes), subjects with clinically established atherosclerotic disease underwent multicontrast carotid magnetic resonance imaging (MRI) to detect plaque tissue composition and high-risk features. Prospective associations between MRI measurements and the AIM-HIGH primary endpoint (fatal and nonfatal myocardial infarction, ischemic stroke, hospitalization for acute coronary syndrome, and symptom-driven revascularization) were analyzed using Cox proportional hazards survival models. RESULTS: Of the 232 subjects recruited, 214 (92.2%) with diagnostic image quality constituted the study population (82% male, mean age 61 ± 9 years, 94% statin use). During median follow-up of 35.1 months, 18 subjects (8.4%) reached the AIM-HIGH endpoint. High lipid content (hazard ratio [HR] per 1 SD increase in percent lipid core volume: 1.57; p = 0.002) and thin/ruptured fibrous cap (HR: 4.31; p = 0.003) in carotid plaques were strongly associated with the AIM-HIGH endpoint. Intraplaque hemorrhage had a low prevalence (8%) and was marginally associated with the AIM-HIGH endpoint (HR: 3.00; p = 0.053). High calcification content (HR per 1 SD increase in percent calcification volume: 0.66; p = 0.20), plaque burden metrics, and clinical risk factors were not significantly associated with the AIM-HIGH endpoint. The associations between carotid plaque characteristics and the AIM-HIGH endpoint changed little after adjusting for clinical risk factors, plaque burden, or AIM-HIGH randomized treatment assignment. CONCLUSIONS: Among patients with clinically established atherosclerotic disease, carotid plaque lipid content and fibrous cap status were strongly associated with systemic cardiovascular outcomes. Markers of carotid plaque vulnerability may serve as novel surrogate markers for systemic atherothrombotic risk.
Authors: R B D'Agostino; M W Russell; D M Huse; R C Ellison; H Silbershatz; P W Wilson; S C Hartz Journal: Am Heart J Date: 2000-02 Impact factor: 4.749
Authors: Rikin A Trivedi; Jean-Marie U-King-Im; Martin J Graves; Jo Horsley; Martin Goddard; Peter J Kirkpatrick; Jonathan H Gillard Journal: Neuroradiology Date: 2004-09 Impact factor: 2.804
Authors: William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub Journal: N Engl J Med Date: 2011-11-15 Impact factor: 91.245
Authors: M Wintermark; S S Jawadi; J H Rapp; T Tihan; E Tong; D V Glidden; S Abedin; S Schaeffer; G Acevedo-Bolton; B Boudignon; B Orwoll; X Pan; D Saloner Journal: AJNR Am J Neuroradiol Date: 2008-02-13 Impact factor: 3.825
Authors: Matthew T Chrencik; Amir A Khan; Lauren Luther; Laila Anthony; John Yokemick; Jigar Patel; John D Sorkin; Siddhartha Sikdar; Brajesh K Lal Journal: J Vasc Surg Date: 2019-03-06 Impact factor: 4.268
Authors: L Saba; C Loewe; T Weikert; M C Williams; N Galea; R P J Budde; R Vliegenthart; B K Velthuis; M Francone; J Bremerich; L Natale; K Nikolaou; J N Dacher; C Peebles; F Caobelli; A Redheuil; M Dewey; K F Kreitner; R Salgado Journal: Eur Radiol Date: 2022-10-04 Impact factor: 7.034
Authors: Jarett D Berry; Anurag Mehta; Kai Lin; Colby R Ayers; Timothy Carroll; Ambarish Pandey; Daniel B Garside; Martha L Daviglus; Chun Yuan; Donald M Lloyd-Jones Journal: Circ Cardiovasc Imaging Date: 2019-09-16 Impact factor: 7.792
Authors: Mahmud Mossa-Basha; Hiroko Watase; Jie Sun; Dean K Shibata; Daniel S Hippe; Niranjan Balu; Thomas Hatsukami; Chun Yuan Journal: Br J Radiol Date: 2019-02-26 Impact factor: 3.039
Authors: Mohammad Alkhalil; Michał Kuzemczak; Nicholas Whitehead; Charalampos Kavvouras; Vladimír Džavík Journal: J Am Heart Assoc Date: 2021-02-15 Impact factor: 5.501